| 我国中小型生物医药高技术公司专利战略的制订 |
| |
| 引用本文： | 谢建平,王洪海.我国中小型生物医药高技术公司专利战略的制订[J].研究与发展管理,2001,13(1):51-56. |
| |
| 作者姓名： | 谢建平 王洪海 |
| |
| 作者单位： | 复旦大学 生命科学学院病原生物学组, |
| |
| 摘 要： | 专利21世纪的主导权利形态，是知识经济的保护神，是许多生物医药高技术公司产生和相关生物制药产业迅速发展的主要原因之一。加入WTO对我国最大的冲击可能来自以专利为主要内容的知识产权。专利战略是中小型生物医药高技术公司整体发展战略中不可或缺的关键之一。作者从一个一线生物技术工作者的角度，集中讨论我国中小型生物医药高技术公司专利战略的制订。
|
| 关 键 词： | 生物医药 高技术公司 专利战略 制订 知识产权 中小企业 |
| 文章编号： | 1004-8308(2001)01-0051-06 |
Formulation of Patent
Strategy for China |
| |
| XIE Jian ping,WANG Hong hai.Formulation of Patent
Strategy for China[J].R&d Management,2001,13(1):51-56. |
| |
| Authors: | XIE Jian ping WANG Hong hai |
| |
| Abstract: | Dominant conformation of patent in 21 century is the protectiongod knowledge economy,and one of the main reasons for emergence of many biological and medicinal high-tech companies and rapid development of corresponding biological and medicinal industries. The most serious impact caused by China’s entrance of WTO may come from property right,which takes patent as its main content. The patent strategy is one of the key development strategies for the medium and small biological and medicinal high-tech companies. From the viewpoint of a worker in the field of biological technology,the author has discussed the formulation of patent strategy for the medium and small companies of biological and medicinal high technology. |
| |
| Keywords: | biology and medicine high tech company patent property right strategy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
| 点击此处可从《研究与发展管理》浏览原始摘要信息 |
| 点击此处可从《研究与发展管理》下载免费的PDF全文 |
